Shots:  In this second installment of Dealmaker 2024, PharmaShots presents an insightful guide to the top M&A deals ranked by deal valueThis report highlights Novo Nordisk’s remarkable achievements, including 24 collaborations spanning acquisitions, company formations, contract services, development and commercialization agreements, facility purchases, licensing options, and platform/product purchases. Collectively, these deals amount to a…